Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue
- PMID: 20133274
- PMCID: PMC2882743
- DOI: 10.1194/jlr.P004960
Paraoxonase 1 R/Q alleles are associated with differential accumulation of saturated versus 20:5n3 fatty acid in human adipose tissue
Abstract
Serum paraoxonase 1 (PON1) function has been associated with human cardiovascular disease. The projected mechanism postulates interaction of PON1 with lipoproteins and insulin signaling resulting in alterations in lipid homeostasis. Recently, PON2 was shown to directly regulate triglyceride accumulation in macrophages and PON1 was detected in the interstitial space of adipocytes. The aims of the present study were a) to examine the relationship of the PON1 function with serum parameters related to lipid homeostasis, and b) to examine a possible role of PON1 in the regulation of lipid composition in the human adipose tissue. Two important genetic variations with functional impact on PON1 activity in humans are the Q192R and the L55M. The present study evaluated the impact of the Q192R and the L55M polymorphisms in a cross-section of the population on the island of Crete, as regards to PON1 activity, plasma lipids/lipoproteins, parameters of the metabolic syndrome, and the fatty acid composition of the adipose tissue. We detected a significant association of the polymorphisms with blood pressure, fasting blood glucose, triglycerides, apolipoprotein B, serum iron, and homocysteine. Furthermore, a novel function is suggested for PON1 on the fatty acid composition in the adipose tissue through the positive association of the R allele with saturated fatty acid and of the Q allele with 20:5n3 fatty acid deposition.
Figures
Similar articles
-
Paraoxonase 1 status in the Thai population.J Hum Genet. 2005;50(6):293-300. doi: 10.1007/s10038-005-0255-7. Epub 2005 May 28. J Hum Genet. 2005. PMID: 15924216
-
Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.Arch Med Res. 2007 May;38(4):403-10. doi: 10.1016/j.arcmed.2007.01.006. Arch Med Res. 2007. PMID: 17416287
-
Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.Asian Pac J Cancer Prev. 2015;16(2):803-9. doi: 10.7314/apjcp.2015.16.2.803. Asian Pac J Cancer Prev. 2015. PMID: 25684529
-
Paraoxonase (PON1) polymorphisms Q192R and L55M are not associated with human longevity: A meta-analysis.Z Gerontol Geriatr. 2016 Jan;49(1):24-31. doi: 10.1007/s00391-015-0892-1. Epub 2015 May 12. Z Gerontol Geriatr. 2016. PMID: 25962362 Review.
-
Review: The role of paraoxonase in cardiovascular diseases.Ann Clin Lab Sci. 2015 Spring;45(2):226-33. Ann Clin Lab Sci. 2015. PMID: 25887882 Review.
Cited by
-
Long term stability of paraoxonase-1 and high-density lipoprotein in human serum.Lipids Health Dis. 2012 May 14;11:53. doi: 10.1186/1476-511X-11-53. Lipids Health Dis. 2012. PMID: 22584062 Free PMC article.
-
Gender-dependent difference in serum paraoxonase 1 levels of Hanwoo, Korean native cattle, and a positive association with meat quality.Asian-Australas J Anim Sci. 2019 Mar;32(3):437-441. doi: 10.5713/ajas.18.0138. Epub 2018 Aug 27. Asian-Australas J Anim Sci. 2019. PMID: 30145873 Free PMC article.
-
Histological and transcriptome-wide level characteristics of fetal myofiber hyperplasia during the second half of gestation in Texel and Ujumqin sheep.BMC Genomics. 2011 Aug 14;12:411. doi: 10.1186/1471-2164-12-411. BMC Genomics. 2011. PMID: 21838923 Free PMC article.
-
Application of metabolomics part II: Focus on fatty acids and their metabolites in healthy adults.Int J Mol Med. 2019 Jan;43(1):233-242. doi: 10.3892/ijmm.2018.3989. Epub 2018 Nov 14. Int J Mol Med. 2019. PMID: 30431095 Free PMC article.
-
Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease.Mol Med Rep. 2017 Jan;15(1):256-262. doi: 10.3892/mmr.2016.5972. Epub 2016 Nov 28. Mol Med Rep. 2017. PMID: 27909725 Free PMC article.
References
-
- Hassett C., Richter R. J., Humbert R., Chapline C., Crabb J. W., Omiecinski C. J., Furlong C. E. 1991. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry. 30: 10141–10149. - PubMed
-
- Mackness M. I., Arrol S., Durrington P. N. 1991. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 286: 152–154. - PubMed
-
- Mertens A., Holvoet P. 2001. Oxidized LDL and HDL: antagonists in atherothrombosis. FASEB J. 15: 2073–2084. - PubMed
-
- Shih D. M., Gu L., Xia Y. R., Navab M., Li W. F., Hama S., Castellani L. W., Furlong C. E., Costa L. G., Fogelman A. M., et al. 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394: 284–287. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous